63 related articles for article (PubMed ID: 7680159)
1. Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up.
Morales JM; Munoz MA; Castellano G; Colina F; Fuertes A; Andres A; Campo C; Blasco A; Hernandez E; Rodicio JL
Transplant Proc; 1993 Feb; 25(1 Pt 2):1450-3. PubMed ID: 7680159
[No Abstract] [Full Text] [Related]
2. Expanding organ availability by using hepatitis C antibody positive donors.
Aswad S; Mendez R; Weingart RG; Mendez R
Transplant Proc; 1993 Jun; 25(3):2270-1. PubMed ID: 7685947
[No Abstract] [Full Text] [Related]
3. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival--a 5- and 10-year follow-up.
Ynares C; Johnson HK; Kerlin T; Crowe D; MacDonell R; Richie R
Transplant Proc; 1993 Feb; 25(1 Pt 2):1466-8. PubMed ID: 7680163
[No Abstract] [Full Text] [Related]
4. Prevalence and clinical significance of hepatitis C in kidney transplantation.
Kubo M; Fujimoto N; Ihara H; Hanafusa T; Nojima M; Koike H; Ichikawa Y; Fukunishi T; Arima M; Nagano S
Transplant Proc; 1994 Aug; 26(4):2121-2. PubMed ID: 7520624
[No Abstract] [Full Text] [Related]
5. Donor hepatitis C antibody virus testing in renal transplantation.
Mendez R; Aswad S; Bogaard T; Khetan U; Asai P; Martinez A; Flores N; Mendez RG
Transplant Proc; 1993 Feb; 25(1 Pt 2):1487-90. PubMed ID: 7680167
[No Abstract] [Full Text] [Related]
6. Antibodies to hepatitis C virus in Omani patients with renal disease.
al-Dhahry SH; Aghanashinikar PN; al-Hasani MK; Buhl MR; Daar AS
Transplant Proc; 1992 Oct; 24(5):1938-9. PubMed ID: 1384203
[No Abstract] [Full Text] [Related]
7. Kidney transplantation from anti-HCV-positive donors to anti-HCV-positive recipients.
Velidedeoğlu E; Simşek H; Haberal M
Transplant Proc; 1993 Jun; 25(3):2330-1. PubMed ID: 7685950
[No Abstract] [Full Text] [Related]
8. Transmission of hepatitis C virus with solid organ transplantation: incidence and clinical significance.
Roth D; Fernandez JA; Babischkin S; De Mattos A; Buck BE; Quan S; Olson L; Burke GW; Nery JR; Esquenazi V
Transplant Proc; 1993 Feb; 25(1 Pt 2):1476-7. PubMed ID: 7680166
[No Abstract] [Full Text] [Related]
9. Hepatitis C in kidney transplant patients.
Oka T; Yasumura T
Transplant Proc; 1996 Jun; 28(3):1163-7. PubMed ID: 8658612
[No Abstract] [Full Text] [Related]
10. Clinical implications of the presence of antibodies to hepatitis C after renal transplantation.
Morales M; Campo C; Castellano G; Colina F; Andres A; Fuertes A; Praga M; Rodicio JL
Transplant Proc; 1992 Feb; 24(1):78-80. PubMed ID: 1371627
[No Abstract] [Full Text] [Related]
11. Hepatitis C virus markers and de novo liver disease after transplantation: a prospective study.
Franco A; Muñoz C; Jimenez L; Verdejo F; Arenas D; Olivares J
Transplant Proc; 1995 Aug; 27(4):2260-1. PubMed ID: 7544499
[No Abstract] [Full Text] [Related]
12. Value of a new four-antigen recombinant immunoblot assay in predicting recurrence of hepatitis C virus infection following liver transplantation.
Lumbreras C; Gimeno C; Colina F; Fuertes A; Lizasoain M; Aguado JM; Loinaz C; Iglesias J; Moreno E; Noriega AR
Transplant Proc; 1993 Feb; 25(1 Pt 2):1463-5. PubMed ID: 7680162
[No Abstract] [Full Text] [Related]
13. Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation.
Aeder MI; Shield CF; Tegtmeier GE; Bayer W; Luger AM; Nelson PW; Pierce GE; Polito A; Wilber JC; Johnson P
Transplant Proc; 1993 Feb; 25(1 Pt 2):1469-71. PubMed ID: 7680164
[No Abstract] [Full Text] [Related]
14. Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.
Durlik M; Gaciong Z; Soluch L; Rowińska D; Kozłowska-Boszko B; Rowiński W; Szmidt J; Lao M
Transplant Proc; 1996 Dec; 28(6):3459-60. PubMed ID: 8962347
[No Abstract] [Full Text] [Related]
15. Recurrent hepatitis C after liver transplantation.
Belli LS; Alberti A; Rondinara GF; De Carlis L; Romani F; Bellati G; Minola E; Zurleni F; Rossetti O; Pirotta V
Transplant Proc; 1993 Aug; 25(4):2635-7. PubMed ID: 7689272
[No Abstract] [Full Text] [Related]
16. Hepatitis C virus infection in kidney transplant recipients.
Valeri M; Pisani F; De Paolis P; Piazza A; Torlone N; Utzeri G; Elli M; Tisone G; Adorno D; Casciani CU
Transplant Proc; 1993 Jun; 25(3):2284-5. PubMed ID: 7685948
[No Abstract] [Full Text] [Related]
17. Clinical outcome of anti-HCV(+) renal allograft recipients.
Lee SW; Kang SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
Transplant Proc; 1996 Jun; 28(3):1501-2. PubMed ID: 8658759
[No Abstract] [Full Text] [Related]
18. Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR.
Cheng IK; Chan DT; Lok AS
Transplant Proc; 1993 Feb; 25(1 Pt 2):1460-2. PubMed ID: 7680161
[No Abstract] [Full Text] [Related]
19. Clinicopathological features of hepatitis C virus infection in dialysis and renal transplantation.
Töz H; Ok E; Yilmaz F; Akarca US; Erensoy S; Zeytinoğlu A; Ozkahya M; Karasu Z; Yüce G; Başçi A
J Nephrol; 2002; 15(3):308-12. PubMed ID: 12116989
[TBL] [Abstract][Full Text] [Related]
20. Incidence of hepatitis C in organ donors and renal transplant recipients.
Szmalc FS; Hubbell C; Tice DG
Transplant Proc; 1993 Aug; 25(4):2677. PubMed ID: 7689273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
